• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非结直肠癌非神经内分泌性肝转移瘤管理的评估工具:一种预后模型的外部验证

Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: External validation of a prognostic model.

作者信息

Tsang Melanie E, Mahar Alyson L, Martel Guillaume, Cleary Sean P, Nanji Sulaiman, Ouellet Jean-François, Hernandez-Alejandro Roberto, Wei Alice C, Hallet Julie

机构信息

Department of Surgery, St. Joseph's Health Centre, Toronto, Ontario, Canada.

Department of Surgery, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Surg Oncol. 2018 Nov;118(6):1006-1011. doi: 10.1002/jso.25228. Epub 2018 Sep 9.

DOI:10.1002/jso.25228
PMID:30196563
Abstract

INTRODUCTION

Selection criteria and benefits for resection of noncolorectal, nonneuroendocrine liver metastases (NCNNELM) remain debated. A prognostic score was developed by the Association Française de Chirurgie (AFC) for patient selection, but not validated. We performed a geographic external validation of this score.

METHODS

Patients with resected NCNNELM from six institutions (2000-2014) were assigned risk groups based on the AFC score. Discrimination was evaluated by visually inspecting separation of overall survival (OS) curves among risk categories. The slope of the continuous score on OS and hazard ratios for risk categories were examined.

RESULTS

Of 165 patients, 53 (32.1%) were low-risk, 85 (51.5%) intermediate-risk, and 27 (16.4%) high-risk. The OS curves did not separate among risk groups: 5-year OS were 60.1% (low), 57.1% (intermediate), and 55.6% (high). The parameter estimate (0.02) indicated lower discrimination than in the AFC cohort. Hazard ratios of 1.05 (0.63 to 1.70) for low vs intermediate, 0.87 (0.46 to 1.64) for low vs high, and 0.83 (0.46 to 1.49) for intermediate vs. high, demonstrated lack of discrimination in OS among risk groups.

CONCLUSION

While long-term survival is achievable, discrimination of the AFC score is not maintained in a geographic external cohort of resected NCNNELM. It is not generalizable to this external population.

摘要

引言

非结直肠癌、非神经内分泌肝转移瘤(NCNNELM)切除的选择标准和益处仍存在争议。法国外科协会(AFC)制定了一个预后评分用于患者选择,但尚未得到验证。我们对该评分进行了地理外部验证。

方法

对来自六个机构(2000 - 2014年)的接受NCNNELM切除的患者根据AFC评分进行风险分组。通过直观检查风险类别之间总生存(OS)曲线的分离情况来评估辨别力。检查了OS上连续评分的斜率以及风险类别的风险比。

结果

165例患者中,53例(32.1%)为低风险,85例(51.5%)为中等风险,27例(16.4%)为高风险。OS曲线在风险组之间没有分离:5年总生存率分别为60.1%(低风险)、57.1%(中等风险)和55.6%(高风险)。参数估计值(0.02)表明辨别力低于AFC队列。低风险与中等风险的风险比为1.05(0.63至1.70),低风险与高风险的风险比为0.87(0.46至1.64),中等风险与高风险的风险比为0.83(0.46至1.49),表明风险组之间在OS方面缺乏辨别力。

结论

虽然可以实现长期生存,但在接受NCNNELM切除的地理外部队列中,AFC评分的辨别力无法维持。它不适用于这个外部人群。

相似文献

1
Assessing tools for management of noncolorectal nonneuroendocrine liver metastases: External validation of a prognostic model.非结直肠癌非神经内分泌性肝转移瘤管理的评估工具:一种预后模型的外部验证
J Surg Oncol. 2018 Nov;118(6):1006-1011. doi: 10.1002/jso.25228. Epub 2018 Sep 9.
2
The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.非结直肠神经内分泌肝脏转移患者手术选择缺乏标准。
World J Surg Oncol. 2020 May 25;18(1):106. doi: 10.1186/s12957-020-01883-y.
3
The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases.肝切除术在非结直肠癌、非神经内分泌转移瘤中的作用:142例观察病例的经验
Ann Surg Oncol. 2005 Jun;12(6):459-66. doi: 10.1245/ASO.2005.06.034. Epub 2005 May 5.
4
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model.非结直肠癌非内分泌性肝转移瘤的肝切除术:1452例患者分析及预后模型的建立
Ann Surg. 2006 Oct;244(4):524-35. doi: 10.1097/01.sla.0000239036.46827.5f.
5
Controversies in defining prognostic relevant selection criteria that determine long-term effectiveness of liver resection for noncolorectal nonneuroendocrine liver metastasis.定义与预后相关的选择标准的争议,这些标准决定了肝切除术治疗非结直肠非神经内分泌肝转移的长期疗效。
Int J Surg. 2015 Dec;24(Pt A):85-90. doi: 10.1016/j.ijsu.2015.11.002. Epub 2015 Nov 14.
6
Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.当代多中心队列中切除的结直肠癌肝转移临床风险评分的验证
HPB (Oxford). 2017 Aug;19(8):675-681. doi: 10.1016/j.hpb.2017.03.010. Epub 2017 May 8.
7
CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.CALy预后评分(癌胚抗原、碱性磷酸酶、淋巴细胞计数)作为单纯肝转移结直肠癌肝切除术后生存的预测指标。
J BUON. 2015 May-Jun;20(3):746-55.
8
Resection of noncolorectal nonneuroendocrine liver metastases: a comparative analysis.非结直肠癌非神经内分泌性肝转移瘤的切除术:一项对比分析
J Am Coll Surg. 2007 Mar;204(3):372-82. doi: 10.1016/j.jamcollsurg.2006.12.019.
9
Long-term outcomes of laparoscopic versus open liver resection for liver metastases from colorectal cancer: A comparative analysis of 168 consecutive cases at a single center.腹腔镜与开腹肝切除术治疗结直肠癌肝转移的长期疗效:单中心168例连续病例的比较分析
Surgery. 2015 Jun;157(6):1065-72. doi: 10.1016/j.surg.2015.01.017. Epub 2015 Mar 16.
10
The Impact of Perioperative Red Blood Cell Transfusions on Long-Term Outcomes after Hepatectomy for Colorectal Liver Metastases.围手术期红细胞输血对结直肠癌肝转移肝切除术后长期预后的影响。
Ann Surg Oncol. 2015 Nov;22(12):4038-45. doi: 10.1245/s10434-015-4477-4. Epub 2015 Mar 10.

引用本文的文献

1
The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases.非结直肠神经内分泌肝脏转移患者手术选择缺乏标准。
World J Surg Oncol. 2020 May 25;18(1):106. doi: 10.1186/s12957-020-01883-y.